A 63 element 1.75 dimensional ultrasound phased array for the treatment of benign prostatic hyperplasia

dc.contributor.authorSaleh, Khaldon Y
dc.contributor.authorSmith, Nadine
dc.date.accessioned2024-01-09T06:47:22Z
dc.date.available2024-01-09T06:47:22Z
dc.date.issued2005-06-17
dc.description.abstractProstate cancer and benign prostatic hyperplasia are very common diseases in older American men, thus having a reliable treatment modality for both diseases is of great importance. The currently used treating options, mainly surgical ones, have numerous complications, which include the many side effects that accompany such procedures, besides the invasive nature of such techniques. Focused ultrasound is a relatively new treating modality that is showing promising results in treating prostate cancer and benign prostatic hyperplasia. Thus this technique is gaining more attention in the past decade as a non-invasive method to treat both diseases. Keyword: ultrasound transducer, 1.75 dimensional array, focusing, matching layer
dc.identifier.citationSaleh, K. Y., & Smith, N. B. (2005). A 63 element 1.75 dimensional ultrasound phased array for the treatment of benign prostatic hyperplasia. Biomedical engineering online, 4, 1-14.
dc.identifier.doihttps://doi.org/10.1186/1475-925X-4-39
dc.identifier.urihttps://dspace.adu.ac.ae/handle/1/359
dc.language.isoen
dc.publisherSpringerLink
dc.titleA 63 element 1.75 dimensional ultrasound phased array for the treatment of benign prostatic hyperplasia
dc.typeArticle

Files

License bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed to upon submission
Description: